Autologous Transplant of EFS-ADA Modified Bone Marrow Cells for ADA-Deficient Severe Combined Immunodeficiency (SCID)
This study is ongoing, but not recruiting participants.
Donald B. Kohn, M.D.
First Posted: May 13, 2013
Last Update Posted: September 27, 2017
National Institute of Allergy and Infectious Diseases (NIAID)
National Human Genome Research Institute (NHGRI)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
Donald B. Kohn, M.D., University of California, Los Angeles
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||September 2018|
|Estimated Primary Completion Date:||July 2018 (Final data collection date for primary outcome measure)|